
Apyx Medical Corporation APYX
$ 3.17
-3.35%
Quarterly report 2025-Q3
added 11-06-2025
Apyx Medical Corporation EV/EBITDA Ratio 2011-2026 | APYX
Annual EV/EBITDA Ratio Apyx Medical Corporation
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| -29.2 | -14.4 | -9.89 | -22.2 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -9.89 | -29.2 | -18.9 |
EV/EBITDA Ratio of other stocks in the Medical devices industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aziyo Biologics
AZYO
|
-4.45 | - | 1.37 % | $ 20.5 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
-244 | - | - | $ 1.77 B | ||
|
Conformis
CFMS
|
-44.1 | - | - | $ 16.4 M | ||
|
Bruker Corporation
BRKR
|
-2.13 | $ 39.27 | -1.36 % | $ 5.85 K | ||
|
Lianluo Smart Limited
LLIT
|
-50.1 | - | 24.59 % | $ 44.8 M | ||
|
Cardiovascular Systems
CSII
|
-93.5 | - | 0.15 % | $ 844 M | ||
|
Cutera
CUTR
|
236 | - | -10.19 % | $ 1.99 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
-4.23 | - | -5.86 % | $ 30.6 M | ||
|
Acutus Medical
AFIB
|
-0.915 | - | -26.83 % | $ 2.62 M | ||
|
Dynatronics Corporation
DYNT
|
-2.59 | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
-1.15 | - | - | $ 10.2 M | ||
|
Cognyte Software Ltd.
CGNT
|
23 | $ 7.82 | 4.13 % | $ 561 M | ||
|
Allied Healthcare Products
AHPI
|
367 | - | 3.58 % | $ 2.21 M | ||
|
Second Sight Medical Products
EYES
|
3.87 | - | -0.97 % | $ 54.4 M | ||
|
AdaptHealth Corp.
AHCO
|
11 | $ 9.4 | -2.49 % | $ 1.27 B | ||
|
Apollo Endosurgery
APEN
|
-7.33 | - | - | $ 475 M | ||
|
EDAP TMS S.A.
EDAP
|
730 | $ 3.99 | -2.68 % | $ 149 M | ||
|
CONMED Corporation
CNMD
|
40.2 | $ 43.41 | -5.2 % | $ 1.35 B | ||
|
Electromed
ELMD
|
26.4 | $ 23.98 | -0.5 % | $ 203 M | ||
|
CryoLife, Inc.
CRY
|
49.1 | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
-2.46 | - | -20.74 % | $ 369 K | ||
|
CHF Solutions, Inc.
CHFS
|
0.013 | - | 1.15 % | $ 34.5 M | ||
|
AxoGen
AXGN
|
-19.1 | $ 29.83 | -2.68 % | $ 1.37 B | ||
|
Axonics Modulation Technologies
AXNX
|
-36 | - | - | $ 3.31 B | ||
|
FONAR Corporation
FONR
|
-33.4 | $ 18.5 | -0.32 % | $ 121 M | ||
|
Soliton, Inc.
SOLY
|
-14 | - | -1.42 % | $ 435 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
90.3 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
-38.6 | - | 0.03 % | $ 1.58 B | ||
|
Accuray Incorporated
ARAY
|
19.9 | $ 0.53 | -4.57 % | $ 54.5 M | ||
|
Misonix, Inc.
MSON
|
-12 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
-20.2 | - | - | $ 111 M | ||
|
Medigus Ltd.
MDGS
|
-9.08 | - | 10.28 % | $ 55.5 M | ||
|
Cytosorbents Corporation
CTSO
|
-4.76 | $ 0.8 | 6.81 % | $ 43.5 M | ||
|
Align Technology
ALGN
|
48.9 | $ 182.64 | -3.38 % | $ 13.7 B | ||
|
Intersect ENT, Inc.
XENT
|
-12.1 | - | - | $ 955 M | ||
|
Inari Medical
NARI
|
261 | - | - | $ 4.23 B | ||
|
Butterfly Network
BFLY
|
-3.9 | $ 3.68 | -4.42 % | $ 779 M | ||
|
BIOLASE
BIOL
|
-86.3 | - | -13.19 % | $ 166 K | ||
|
Abbott Laboratories
ABT
|
20.3 | $ 113.61 | -0.45 % | $ 198 B | ||
|
NuVasive
NUVA
|
16.3 | - | - | $ 2.07 B | ||
|
Nevro Corp.
NVRO
|
-23.6 | - | - | $ 217 M | ||
|
BioSig Technologies
BSGM
|
-1.88 | - | 37.08 % | $ 85.7 M | ||
|
Boston Scientific Corporation
BSX
|
25.2 | $ 73.85 | -3.11 % | $ 109 B | ||
|
Helius Medical Technologies
HSDT
|
-0.0925 | $ 1.98 | -6.6 % | $ 1.2 M | ||
|
Alphatec Holdings
ATEC
|
-8.6 | $ 13.02 | -3.34 % | $ 1.95 B | ||
|
InMode Ltd.
INMD
|
23.3 | $ 13.6 | -0.29 % | $ 879 M | ||
|
Edwards Lifesciences Corporation
EW
|
39.2 | $ 85.28 | -2.18 % | $ 49.9 B | ||
|
IRIDEX Corporation
IRIX
|
-11.2 | $ 1.43 | 1.42 % | $ 23.1 M | ||
|
IRadimed Corporation
IRMD
|
46 | $ 104.29 | 0.53 % | $ 1.32 B |